NM_001003694.2:c.2T>G
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PVS1_SupportingPM2PP5_Moderate
The NM_001003694.2(BRPF1):c.2T>G(p.Met1?) variant causes a start lost change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Consequence
NM_001003694.2 start_lost
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BRPF1 | NM_001003694.2 | c.2T>G | p.Met1? | start_lost | Exon 2 of 14 | ENST00000383829.7 | NP_001003694.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Intellectual developmental disorder with dysmorphic facies and ptosis Pathogenic:1
The BRPF1 c.2T>G (p.Met1?) variant is rare and is not present in the gnomAD human population database. This variant changes the translation initiator methionine codon. It is not known whether protein translation is completely prevented or if an abnormal protein is produced using an alternate methionine. This variant has not been previously reported in association with autosomal dominant intellectual developmental disorder with dysmorphic facies and ptosis (IDDDFP) . However, another variant affecting the initiator methionine has been reported (ClinVar ID:489079). This variant is considered likely pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.